Skip to content

LONA LONA Restricted Cash

Restricted Cash at other companies

Aura Biosciences, Inc. logo
Aura Biosciences, Inc.AURA
$768K0.0%
Erasca, Inc. logo
Erasca, Inc.ERAS
$408K0.0%
Immunome logo
ImmunomeIMNM
$210K+110%
Arcus Biosciences logo
Arcus BiosciencesRCUS
$3M0.0%

Other financials

Income statement

See full
Operating income-$17.2M-80.5%
Net income-$32.9M-260%
EPS (diluted)-$1.73+26.1%

Balance sheet

See full
Cash & equivalents$32.8M+24.3%
Total debt$691.0K-38.2%
Total equity$49.3M+32.1%
Total assets$71.6M+64.5%

Cash flow

See full
Operating cash flow-$20.9M-42.5%
CapEx$28.0K-15.2%
Free cash flow-$26.0M+1.1%

Valuation

See full
Market cap$86.33M+223%
Enterprise value$54.18M

Returns & leverage

See full
Return on equity-298.8%-726pp
Debt / equity0.0×
Current ratio10.4×+3.1×

Where this comes from

Reported directly by LONA in its filing.

Tagged under the XBRL concept us-gaap:RestrictedCashNoncurrent.

The official record: LONA’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about LONA's restricted cash.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is LONA's restricted cash?
LONA (LONA) reported restricted cash of $631K in Q1 2026.
How has LONA's restricted cash changed year-over-year?
LONA's restricted cash decreased by 0.0% year-over-year, from $631K to $631K.
What is the long-term trend for LONA's restricted cash?
Over 3 years (2022 to 2025), LONA's restricted cash has grown at a 14.5% compound annual growth rate (CAGR), from $420K to $631K.
What does restricted cash mean?
Cash restricted for specific purposes by contractual, regulatory, or legal requirements — not available for general corporate use.